The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Cystic Fibrosis (Respiratory) - Drugs In Development, 2021
US$ 2,500.00
Cystic Fibrosis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2021, pro...
July 2021
545 pages
Drug Overdose - Drugs In Development, 2021
US$ 2,000.00
Drug Overdose - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Overdose - Drugs In Development, 2021, provides an overview...
July 2021
102 pages
Esophageal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Esophageal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Esophageal Cancer - Drugs In Development, 2021, pr...
July 2021
2058 pages
Fibrosarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Fibrosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma - Drugs In Development, 2021, provides an...
July 2021
202 pages
Free Fatty Acid Receptor 1 - Drugs In Development, 2021
US$ 3,500.00
Free Fatty Acid Receptor 1 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Free Fatty Acid Receptor 1 - Drugs In Development, 2021'; Free Fatty Acid Receptor 1 (G Prot...
July 2021
69 pages
Glaucoma (Ophthalmology) - Drugs In Development, 2021
US$ 2,500.00
Glaucoma (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glaucoma - Drugs In Development, 2021, provides an ove...
July 2021
470 pages
Heavy Metal Poisoning - Drugs In Development, 2021
US$ 2,000.00
Heavy Metal Poisoning - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heavy Metal Poisoning - Drugs In Development, 2021, provi...
July 2021
36 pages
Heparanase - Drugs In Development, 2021
US$ 3,500.00
Heparanase - Drugs In Development, 2021 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 15 molecules. Out of which approximately 14...
July 2021
63 pages
Hepatocyte Growth Factor - Drugs In Development, 2021
US$ 3,500.00
Hepatocyte Growth Factor - Drugs In Development, 2021 SUMMARY Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Hepatocyte growth factor (HGF) is a paracrine cellular growth and mo...
July 2021
99 pages
High Mobility Group Protein B1 - Drugs In Development, 2021
US$ 3,500.00
High Mobility Group Protein B1 - Drugs In Development, 2021 SUMMARY According to the recently published report 'High Mobility Group Protein B1 - Drugs In Development, 2021'; High Mobility Group Protei...
July 2021
57 pages
Hodgkin Lymphoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Hodgkin Lymphoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma - Drugs In Development, 2021, prov...
July 2021
1353 pages
